| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |